<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01053533</url>
  </required_header>
  <id_info>
    <org_study_id>20100118</org_study_id>
    <nct_id>NCT01053533</nct_id>
  </id_info>
  <brief_title>A Pragmatic Randomized Controlled Trial of Chinese Herbal Medicine for Severe Pandemic H1N1 Influenza</brief_title>
  <acronym>200907001-2A</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Ditan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing University of Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>State Administration of Traditional Chinese Medicine of the People's Republic of China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>China Academy of Chinese Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beijing Ditan Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the effectiveness and safety of Chinese herbal medicines
      for severe pandemic H1N1 influenza.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">April 2010</completion_date>
  <primary_completion_date type="Anticipated">April 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of complication</measure>
    <time_frame>10 days for pandemic H1N1 influenza patients with risk factors for severe H1N1 influenza;28 days for severe pandemic H1N1 influenza patients.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>mortality of pandemic H1N1 influenza and all-cause mortality(only for severe pandemic H1N1 influenza patients)</measure>
    <time_frame>28 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>proportion of deteriorating into severe H1N1 influenza (only for pandemic H1N1 influenza patients with risk factors for severe H1N1 influenza)</measure>
    <time_frame>10 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>time to allaying a fever</measure>
    <time_frame>10 days for pandemic H1N1 influenza patients with risk factors for severe H1N1 influenza;28 days for severe pandemic H1N1 influenza patients</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to symptom relief</measure>
    <time_frame>10 days for pandemic H1N1 influenza patients with risk factors for severe H1N1 influenza;28 days for severe pandemic H1N1 influenza patients</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time and proportion of H1N1 virus turning to negative</measure>
    <time_frame>10 days for pandemic H1N1 influenza patients with risk factors for severe H1N1 influenza;28 days for severe pandemic H1N1 influenza patients</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>direct medical cost</measure>
    <time_frame>10 days for pandemic H1N1 influenza patients with risk factors for severe H1N1 influenza;28 days for severe pandemic H1N1 influenza patients</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>safety outcome(adverse effects)</measure>
    <time_frame>10 days for pandemic H1N1 influenza patients with risk factors for severe H1N1 influenza;28 days for severe pandemic H1N1 influenza patients</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>days in hospital</measure>
    <time_frame>10 days for pandemic H1N1 influenza patients with risk factors for severe H1N1 influenza;28 days for severe pandemic H1N1 influenza patients</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>dose and usage of hormones(only for severe pandemic H1N1 influenza patients)</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammation of lung tissue(only for severe pandemic H1N1 influenza patients)</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1100</enrollment>
  <condition>Influenza A Virus, H1N1 Subtype</condition>
  <arm_group>
    <arm_group_label>Chinese herbal medicines plus western therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>western therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>including supportive therapy and antivirus therapy when necessary</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chinese herbal medicines plus western therapy</intervention_name>
    <description>injections of Chinese herbal medicines and Chinese herbal medicines decoction&amp; supportive therapy and antivirus therapy when necessary</description>
    <arm_group_label>Chinese herbal medicines plus western therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>western therapy</intervention_name>
    <description>supportive therapy and antivirus therapy when necessary</description>
    <arm_group_label>western therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of severe pandemic H1N1 influenza patients and pandemic H1N1
             influenza patients with risk factors for severe H1N1 influenza

          -  Rapid Diagnostic Tests:positive

          -  Age≥6 years

          -  Influenza symptoms occurred less than 48 hours and body temperature≥37.5℃ for pandemic
             H1N1 influenza patients with risk factors for severe H1N1 influenza

        Exclusion Criteria:

          -  Suffering from mental illness

          -  Attending other clinical studies on influenza

          -  Critical pandemic H1N1 influenza patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mao Yu</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100015</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu Mao</last_name>
      <email>myqmz58@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Guang Yu Wang</last_name>
      <email>influenzatcm@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>Guang YU Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 19, 2010</study_first_submitted>
  <study_first_submitted_qc>January 20, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2010</study_first_posted>
  <last_update_submitted>June 7, 2010</last_update_submitted>
  <last_update_submitted_qc>June 7, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 8, 2010</last_update_posted>
  <responsible_party>
    <name_title>Beijing Di Tan Hospital</name_title>
    <organization>Beijing Di Tan Hospital</organization>
  </responsible_party>
  <keyword>Chinese herbal medicines</keyword>
  <keyword>pandemic H1N1 influenza</keyword>
  <keyword>effectiveness</keyword>
  <keyword>safety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Influenza, Human</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

